Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001 is a phase 2, randomised interventional study registered as NCT05254327 by University of Nebraska, with a registry enrolment figure of 118 participants, started 2022-08-15 and due to reach its primary completion in 2027-05. Interventions recorded: BMX-001. Conditions listed: Rectal Cancer. Primary outcome: Efficacy of BMX-001 as measured by Grade 3 and above associated with gastrointestinal Toxicities; Efficacy of BMX-001 as measured by Grade 3 and above associated with genitourinary Toxicities; Efficacy of BMX-001 as measured by Grade 3 and above associated with skin Toxicities. Colorectal eligibility wording from the registry: "Patients with pathologically confirmed locally advanced rectal adenocarcinoma who will be receiving total neoadjuvant therapy regimen with curative intent". Sites: United States. No results are recorded here; the registry entry is the source.